| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 50.418 | 56.409 | 195.613 | 311.959 | 317.760 | 266.887 | 344.708 | 373.290 | 356.555 | 356.687 |
| Total Income - EUR | 51.545 | 56.830 | 195.816 | 312.257 | 318.055 | 267.305 | 345.027 | 376.290 | 369.718 | 381.521 |
| Total Expenses - EUR | 30.894 | 18.527 | 115.970 | 193.517 | 212.702 | 217.650 | 209.658 | 224.185 | 222.937 | 218.883 |
| Gross Profit/Loss - EUR | 20.651 | 38.302 | 79.846 | 118.741 | 105.353 | 49.655 | 135.369 | 152.105 | 146.781 | 162.638 |
| Net Profit/Loss - EUR | 19.293 | 37.166 | 77.888 | 115.618 | 102.172 | 46.982 | 131.987 | 148.418 | 143.158 | 151.421 |
| Employees | 3 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 5 | 4 |
Check the financial reports for the company - Oculus - Medserv Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 1.684 | 24.300 | 20.648 | 28.477 | 19.484 | 9.935 | 4.554 | 0 |
| Current Assets | 99.125 | 49.593 | 134.033 | 233.120 | 244.490 | 223.698 | 305.517 | 276.607 | 347.131 | 495.777 |
| Inventories | 0 | 0 | 3.313 | 4.759 | 2.029 | 3.134 | 4.594 | 4.760 | 5.338 | 3.811 |
| Receivables | 4.143 | 2.819 | 393 | 454 | 227 | 222 | 223 | 0 | 190 | 99.193 |
| Cash | 94.982 | 46.774 | 130.327 | 227.907 | 242.235 | 220.342 | 300.700 | 271.846 | 341.603 | 392.773 |
| Shareholders Funds | 97.651 | 47.816 | 124.894 | 238.220 | 242.614 | 241.473 | 308.525 | 274.332 | 337.551 | 151.469 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.474 | 1.777 | 10.823 | 19.200 | 22.524 | 10.701 | 16.862 | 12.209 | 14.134 | 344.308 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oculus - Medserv Srl